Purpose The sequelae of cancer treatment may increase systemic inflammation and create
a phenotype at increased risk of functional decline and comorbidities, leading to premature …

PURPOSE Older breast cancer survivors are at increased risk of clinical decline after
adjuvant chemotherapy. This study aimed to evaluate whether inflammatory markers …

Purpose Chronic inflammation is a significant physiologic feature of frailty; however, its role
and clinical utility in cancer-related frailty remains unknown. We sought to determine if pre …

Purpose: This study seeks to define immunologic and inflammatory variables associated
with persistent post-treatment fatigue in breast cancer survivors. Experimental Design …

Purpose To prospectively investigate accelerated aging and its association with total
mortality and breast cancer-specific mortality/recurrence among breast cancer survivors …

Background Inflammation contributes to poor behavioral, functional, and clinical outcomes in
cancer survivors. We examined whether standard cancer treatments—radiation and …

OBJECTIVE: The purpose of this study was to assess the impact of aging, comorbidities and
symptoms on physical function in patients surviving 20years since adjuvant treatment for …

BACKGROUND: The majority of cancer survivors are aged≥ 65 years, yet, historically,
cancer research has focused infrequently on older patients. The objective of this study was …

Radiation and chemotherapy are effective treatments for cancer, but are also toxic to healthy
cells. Little is known about whether prior exposure to these treatments is related to markers …

Quality of life (QOL) is an important outcome for cancer survivors; but although age is a
major risk factor, most breast cancer survivorship studies are conducted with younger …